Global Oncology Breakthroughs Being Fueled by Advancements in Clinical Trials and New Therapies Jul 8, 2025 08:50AM
Global Radiotherapy Market Expected to Reach $9.62 Billion By 2030 Realizing Growth Due to Technological Advancements Mar 27, 2025 08:30AM
AZN DEADLINE: TOP RANKED ROSEN LAW FIRM Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN Feb 20, 2025 07:30PM
AZN DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN Feb 18, 2025 01:05PM
AZN DEADLINE: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN Feb 17, 2025 01:14PM
View Older Stories

Feb 16, 2025 12:21PM AZN DEADLINE ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by th
Feb 14, 2025 05:45PM AZN DEADLINE NOTICE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm -
Feb 13, 2025 05:40PM AZN DEADLINE ALERT: ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 12, 2025 05:44PM AZN DEADLINE ALERT: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - A
Feb 11, 2025 12:32PM ROSEN, A TOP RANKED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 8, 2025 01:32PM ROSEN, LEADING TRIAL ATTORNEYS, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 7, 2025 12:12PM ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important February 21 Deadline in Securities Class Action First Filed by the Firm - AZN
Feb 3, 2025 06:47PM ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 23, 2025 05:06PM ROSEN, A LONGSTANDING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 22, 2025 05:01PM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 22, 2025 08:30AM Demand for Advanced Pancreatic Cancer Treatments at All Time High as Promising Options Come into Focus
Jan 20, 2025 02:16PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 19, 2025 12:03PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 17, 2025 05:03PM ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 16, 2025 04:58PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 15, 2025 04:53PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 14, 2025 04:48PM ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 13, 2025 04:47PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 12, 2025 04:47PM ROSEN, A HIGHLY-REGARDED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 11, 2025 04:47PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 9, 2025 07:11PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 8, 2025 07:06PM ROSEN, NATIONAL TRIAL LAWYERS, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 7, 2025 07:05PM ROSEN, A LONGSTANDING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 7, 2025 08:00AM Asher Bio Announces Clinical Supply Agreement to Enable Evaluation of Etakafusp Alfa (AB248) in Combination with Rilvegostomig in a Global Phase 1b/2 Study in Non-Small Cell Lung Cancer (NSCLC)
Jan 5, 2025 10:06PM ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 4, 2025 10:05PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 3, 2025 10:05PM ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 2, 2025 10:04PM ROSEN, A RANKED AND LEADING FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Jan 1, 2025 10:03PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 31, 2024 10:03PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 30, 2024 10:02PM ROSEN, A TOP-RANKED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 29, 2024 10:01PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 28, 2024 10:00PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 27, 2024 09:59PM ROSEN, A TOP-RANKED LAW FIRM, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 26, 2024 09:56PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 26, 2024 09:00AM Achievements and Progress Heading into 2025 for Oncology Treatments and Therapies Fuel an Optimistic Outlook
Dec 25, 2024 09:55PM ROSEN, LEADING INVESTOR COUNSEL Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 24, 2024 09:54PM ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 23, 2024 03:30PM ROSEN, NATIONAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm - AZN
Dec 20, 2024 10:59PM ROSEN, A LEADING LAW FIRM, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
Dec 19, 2024 07:51PM ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
Dec 18, 2024 04:54PM ROSEN, LEADING INVESTOR COUNSEL, Encourages AstraZeneca PLC Investors to Inquire About Securities Class Action Investigation - AZN
Jun 20, 2024 10:00AM Pancreatic Cancer Market Is Projecting to Expand As NCI-Funded Research Expects to Empower Market Growth
May 8, 2024 08:30AM Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Billion in 2024
Apr 16, 2024 08:00AM Asher Bio Closes $55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials
Feb 7, 2024 06:53AM SOPHiA GENETICS (SOPH) and AstraZeneca Spain (AZN) Commit to Increasing Ovarian Cancer Testing in Spain
Feb 7, 2024 06:51AM SOPHiA GENETICS and AstraZeneca Spain Commit to Increasing Ovarian Cancer Testing in Spain
Dec 4, 2023 07:30AM Absci Corporation (ABSI) Announces Collaboration with AstraZeneca to Advance AI-Driven Oncology Candidate
Oct 18, 2023 08:00AM SOPHiA GENETICS Enters New Collaboration with Memorial Sloan Kettering Cancer Center and AstraZeneca to Address Global Inequalities in Comprehensive Cancer Care
Sep 14, 2023 02:00AM AstraZeneca advances UK clean heat and energy efficiencies with £100m commitment
View Older Stories